INFORMATION
STATEMENT
We
Are Not Asking You For A Proxy And You Are Requested Not To Send Us A Proxy.
You
are not being asked to approve anything. This Information Statement is being provided to you solely for your information.
GENERAL
INFORMATION
Why
am I receiving these materials?
This
Information Statement is mailed or furnished to holders of record of the outstanding common stock of Cocrystal Pharma, Inc., a
Delaware corporation (the “Company”), in connection with the action by written consent of shareholders taken without
a meeting to approve a reverse stock split (the “Reverse Stock Split”) which is described in this Information Statement.
You are urged to read this Information Statement carefully and in its entirety for a description of the Reverse Stock Split.
The date of this Information
Statement is October 16, 2017 and is first being mailed on or about October 17, 2017. Pursuant to the Delaware General
Corporation Law (the “DGCL”), the Company is required to provide prompt notice to the shareholders who have not consented
in writing.
The
Board of Directors of the Company (the “Board”) is not soliciting your proxy or consent in connection with the Reverse
Stock Split.
What
action was taken by written consent?
We
obtained written consent by the holders of the majority of the voting power of the Company’s outstanding common stock (the
“Majority Shareholders”), approving the amendment to the Company’s Certificate of Incorporation (the “Certificate”)
to amend the Certificate to effect a Reverse Stock Split at a ratio of one-for-15, one-for-50, or any Ratio in between, (the “Split
Ratio”).
When
is the record date?
The close of business
on October 2, 2017 is the record date (the “Record Date”) for the determination of shareholders entitled consent and
entitled to receive this Information Statement.
What vote was obtained to approve the
amendment to the Certificate of Incorporation described in this Information Statement?
In accordance with
Sections 228 and 242 of the DGCL, if the Board adopts a resolution to amend the Certificate, an affirmative vote of a majority
of the outstanding common stock entitled to vote is required. On September 19, 2017, the Board adopted this resolution. On October
2, 2017, shareholder approval was obtained through the written consent of our Majority Shareholders. Of the 726,531,530 outstanding
common stock, the Majority Shareholders holding 422,809,149 votes or 58.2% of the outstanding common stock, executed a written
consent to effectuate the Reverse Stock Split.
Therefore, a special meeting
of the shareholders to approve the Reverse Stock Split is unnecessary. If shareholders had been provided an opportunity to vote
at a meeting, an affirmative vote of a majority of the outstanding common stock would also have been required.
When
will the Reverse Stock Split become effective?
Once we decide to implement
the Reverse Stock Split, it would become effective on the date of filing of a Certificate of Amendment to our Certificate with
the office of the Secretary of State of the State of Delaware (the “Effective Date”). However, a U.S. Securities and
Exchange Commission (the “SEC”) rule requires us to first give 10 days’ prior notice to the Financial Industry
Regulatory Authority (“FINRA”). Additionally, the Certificate of Amendment may not be filed until at least
20 calendar days after the mailing of this Information Statement.
Who
is paying the cost of this Information Statement?
The
entire cost of furnishing this Information Statement will be paid by the Company.
Does
any person have an interest in the adoption of the Reverse Stock Split?
No
security holders receive an extra or special benefit not shared on a pro-rata basis by all other holders of the same class.
AMENDMENT
TO THE CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT
Overview
The
Majority Shareholders have approved an amendment to our Certificate to effect a Reverse Stock Split at an exchange ratio of the
Split Ratio.
The
Reverse Stock Split will have no effect on the par value of our common stock. No fractional shares will be issued in connection
with the Reverse Stock Split. The proposed form of amendment to our Certificate to implement the Reverse Stock Split is attached
to this Information Statement as
Appendix A
.
Our
common stock is currently quoted on the OTCQB under the symbol “COCP”. On the Record Date, the last sale price of
our common stock was $0.27 per share. Our Board believes that our relatively low per-share market price of our common stock impairs
the acceptability of the common stock to potential investors and certain members of the investing public, including institutional
investors. Our Board also believes that the Reverse Stock Split will move the Company closer to being eligible for listing on
The Nasdaq Stock Market (“Nasdaq”).
Our
Board may elect not to implement the approved Reverse Stock Split at its sole discretion. Our Board has the maximum flexibility
to react to current market conditions and to therefore achieve the purposes of the Reverse Stock Split, if implemented, and to
act in the best interests of the Company and our shareholders.
Because
the Split Ratio is a range, the actual Ratio will be determined by our Board.
Purpose
of the Reverse Stock Split
The
Board believes that a Reverse Stock Split is desirable for a number of reasons, including:
Increase
in Eligible Institutional and Other Investors.
We believe a Reverse Stock Split may increase the price of our common stock
or potentially decrease its volatility, and thus may allow a broader range of institutional investors with the ability to invest
in our stock. For example, many funds and institutions have investment guidelines and policies that prohibit them from investing
in stocks whose price is below a certain threshold. We believe that increased institutional investor interest in the Company and
our common stock will potentially increase the overall market for our common stock.
Increase Analyst
and Broker Interest.
We believe a Reverse Stock
Split would help increase analyst and broker-dealer interest in our common stock as many brokerage and investment advisory firms’
policies can discourage analysts, advisors, and broker-dealers from following or recommending companies with low stock prices.
Because of the trading volatility and lack of liquidity often associated with lower-priced stocks, many brokerage houses have
adopted investment guidelines and policies and practices that either prohibit or discourage them from investing or trading such
stocks or recommending them to their clients and customers. Some of those guidelines, policies and practices may also function
to make the processing of trades in lower-priced stocks economically unattractive to broker-dealers. While we recognize we may
remain a “penny stock” under the rules of the SEC because a penny stock trades at less than $5.00, we think the
increase from the Reverse Stock Split will position us better if our business continues to increase as we expect. Because brokers’
commissions and dealer mark-ups/mark-downs on transactions in lower-priced stocks generally represent a higher percentage of the
stock price than commissions and mark-ups/mark-downs on higher-priced stocks, the current average price per share of our common
stock can result in shareholders or potential shareholders paying transaction costs representing a higher percentage of the total
share value than would otherwise be the case if the share price were substantially higher.
Move
the Company Closer to Listing on Nasdaq.
By potentially increasing our stock price, the Reverse Stock Split would potentially
increase our minimum bid or share price required for the initial listing requirements for Nasdaq. We would like to eventually
apply for listing on Nasdaq. We currently do not meet their listing requirements, including the minimum bid price. The Reverse
Stock Split will not cause us to meet all of the listing requirements for Nasdaq. But we believe the Reverse Stock Split will
increase our stock price which may help us move towards eventually meeting the minimum share price requirements. We are not certain
that the Reverse Stock Split will have a long-term positive effect on the market price of our common stock, or increase our ability
to be listed or approved for trading on Nasdaq.
Risks
of the Reverse Stock Split
The
Reverse Stock Split may not increase our market capitalization, which would prevent us from realizing some of the anticipated
benefits of the Reverse Stock Split.
The market price of our common stock is based on a number of factors that
may be unrelated to the number of shares outstanding. These factors may include our performance, general economic and market conditions
and other factors, many of which are beyond our control. The market price per share may not rise, or it may remain constant in
proportion to the reduction in the number shares outstanding before the Reverse Stock Split. Accordingly, the total market capitalization
of our common stock after the Reverse Stock Split may be lower than the total market capitalization before the Reverse Stock Split.
In the future, the market price of common stock following the Reverse Stock Split may not equal or exceed the market price prior
to the Reverse Stock Split.
Effects
of the Reverse Stock Split
Reduction
of Shares Held by Individual Shareholders
. After the Effective Date each common shareholder will own fewer shares of our
common stock. However, the Reverse Stock Split will affect all of our common shareholders uniformly and will not affect any common
shareholder’s percentage ownership interests in us, except to the extent that the Reverse Stock Split results in any of
our shareholders owning a fractional share as described below. As discussed further below, we will pay cash in lieu of fractional
shares. The number of shareholders of record will not be affected by the Reverse Stock Split (except to the extent that any shareholder
holds only a fractional share interest and will receives cash for such interest after the Reverse Stock Split). However, if the
Reverse Stock Split is approved, it will increase the number of shareholders who own “odd lots” of less than 100 shares
of our common stock. Brokerage commissions and other costs of transactions in odd lots may be higher than the costs of transactions
of more than 100 shares of common stock.
Change
in Number and Exercise Price of Employee and Equity Awards
. The Reverse Stock Split will reduce the number of shares of
common stock available for issuance under our equity plans and agreements in proportion to the Split Ratio. Under the terms of
our outstanding equity and option awards, the Reverse Stock Split will cause a reduction in the number of shares of common stock
issuable upon exercise or vesting of such awards in proportion to the Split Ratio of the Reverse Stock Split which is ultimately
approved by our Board and will cause a proportionate increase in the exercise price of such awards to the extent they are stock
options. The number of shares authorized for future issuance under our equity plans will also be proportionately reduced. The
number of shares of common stock issuable upon exercise or vesting of stock option awards will be rounded to the nearest whole
share and no cash payment will be made in respect of such rounding. Warrant and other convertible security holders, if any, will
also see a similar reduction of the number of shares such instruments are convertible into stock option holders described above.
Regulatory
Effects
. Our common stock is currently registered under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange
Act”), and we are subject to the periodic reporting and other requirements of the Exchange Act. The Reverse Stock Split
will not affect the registration of the common stock under the Exchange Act or our obligation to publicly file financial and other
information with the SEC. If the Reverse Stock Split is implemented, our common stock will continue to trade on the OTCQB.
In
addition to the above, the Reverse Stock Split will have the following effects upon our common stock:
The
number of shares owned by each holder of common stock will be reduced;
|
●
|
The
per share loss and net book value of our common stock will be increased because there will be a lesser number of shares of
our common stock outstanding;
|
|
|
|
|
●
|
The
authorized common stock and the par value of the common stock will remain $0.001 per share;
|
|
|
|
|
●
|
The
stated capital on our balance sheet attributable to the common stock will be decreased and the additional paid-in capital
account will be credited with the amount by which the stated capital is decreased;
|
|
|
|
|
●
|
All
outstanding options, warrants, and convertible securities entitling the holders thereof to purchase shares of common stock,
if any, will enable such holders to purchase, upon exercise thereof, fewer of the number of shares of common stock which such
holders would have been able to purchase upon exercise thereof immediately preceding the Reverse Stock Split, at the same
total price (but a higher per share price) required to be paid upon exercise thereof immediately preceding the Reverse Stock
Split;
|
|
|
|
|
●
|
As
mentioned above, the Reverse Stock Split may result in some shareholders owning “odd lots” of less than 100 shares
of common stock. Odd lot shares may be more difficult to sell, and brokerage commissions and other costs of transactions in
odd lots are generally somewhat higher than the costs of transactions in “round lots” of even multiples of 100
shares.
|
Shares
of common stock after the Reverse Stock Split will be fully paid and non-assessable. The amendment will not change any of the
other the terms of our common stock. The shares of common stock after the Reverse Stock Split will have the same voting rights
and rights to dividends and distributions and will be identical in all other respects to the shares of common stock prior to the
Reverse Stock Split.
Because the number of
authorized shares of our common stock will not be reduced, an overall effect of the Reverse Stock Split of the outstanding common
stock will be an increase in authorized but unissued shares of our common stock. These shares may be issued by our Board in its
sole discretion. See “Anti-Takeover Effects of the Reverse Stock Split” below. Although the Company has no specific
plans for the issuance of the common stock which would become newly available as a result of the reverse stock split, it anticipates
raising capital in the near future in order to fund its operations. The Company continues to engage in preliminary discussions
with potential investors and broker-dealers but no terms have been agreed upon. Any future issuance will have the effect of diluting
the percentage of stock ownership and voting rights of the present holders of our common stock.
Once
we implement a Reverse Stock Split, the share certificates representing the shares will continue to be valid. In the future, new
share certificates will be issued reflecting the Reverse Stock Split, but this in no way will affect the validity of your current
share certificates. The Reverse Stock Split will occur without any further action on the part of our shareholders. After the Effective
Date each share certificate representing the shares prior to the Reverse Stock Split will be deemed to represent the number of
shares shown on the certificate, divided by the Split Ratio. Certificates representing the shares after the Reverse Stock Split
will be issued in due course as share certificates representing shares prior to the Reverse Stock Split are tendered for exchange
or transfer to our transfer agent.
We request that shareholders do not send in any of their stock certificates at this time
.
As
applicable, new share certificates evidencing new shares following the Reverse Stock Split that are issued in exchange for share
certificates issued prior to the Reverse Stock Split representing old shares that are restricted shares will contain the same
restrictive legend as on the old certificates. Also, for purposes of determining the term of the restrictive period applicable
to the new shares after the Reverse Stock Split, the time period during which a shareholder has held their existing pre-Reverse
Stock Split old shares will be included in the total holding period.
Procedure
for Implementing the Reverse Stock Split
The
Reverse Stock Split would become effective upon the filing of a Certificate of Amendment to our Certificate with the Secretary
of State of the State of Delaware. The timing of the filing of the Certificate of Amendment that will effectuate the Reverse Stock
Split will be determined by our Board based on its evaluation as to when such action will be the most advantageous to us and our
shareholders. In addition, our Board reserves the right, notwithstanding shareholder approval and without further action by the
shareholders, to elect not to proceed with the Reverse Stock Split if, at any time prior to filing the amendment to our Certificate,
our Board, in its sole discretion, determines that it is no longer in our best interest and the best interests of our shareholders
to proceed with the Reverse Stock Split. If a Certificate of Amendment effecting the Reverse Stock Split has not been filed with
the Secretary of State of the State of Delaware by the close of one year from the Record Date, our Board will abandon the Reverse
Stock Split.
After
the filing of the Certificate of Amendment, our common stock will have a new CUSIP number, which is a number used to identify
our equity securities, and stock certificates with the older CUSIP number will need to be exchanged for stock certificates with
the new CUSIP number by following the procedures described below.
As
soon as practicable after the Reverse Stock Split our transfer agent will act as exchange agent for purposes of implementing the
exchange of stock certificates for record holders (i.e., shareholders who hold their shares directly in their own name and not
through a broker). Record holders of pre-Reverse Stock Split shares will be asked to surrender to the transfer agent certificates
representing pre-Reverse Stock Split shares in exchange for a book entry with the transfer agent or certificates representing
post-Reverse Stock Split shares in accordance with the procedures to be set forth in a letter of transmittal to be sent by us.
No new certificates will be issued to a shareholder until such shareholder has surrendered such shareholder’s outstanding
certificate(s) together with the properly completed and executed letter of transmittal to the exchange agent.
For
street name holders of pre-Reverse Stock Split shares (i.e., shareholders who hold their shares through a broker), your broker
will make the appropriate adjustment to the number of shares held in your account following the Effective Date.
SHAREHOLDERS
SHOULD NOT DESTROY ANY STOCK CERTIFICATE(S) AND SHOULD NOT SUBMIT ANY CERTIFICATE(S) UNTIL REQUESTED TO DO SO.
No
service charges, brokerage commissions or transfer taxes will be payable by any shareholder, except that if any new stock certificates
are to be issued in a name other than that in which the surrendered certificate(s) are registered it will be a condition of such
issuance that (1) the person requesting such issuance pays all applicable transfer taxes resulting from the transfer (or prior
to transfer of such certificate, if any) or establishes to our satisfaction that such taxes have been paid or are not payable,
(2) the transfer complies with all applicable federal and state securities laws, and (3) the surrendered certificate is properly
endorsed and otherwise in proper form for transfer.
Payment
for Fractional Shares
No
fractional shares of common stock will be issued as a result of the Reverse Stock Split. Instead, shareholders who otherwise would
be entitled to receive fractional shares, upon surrender to the exchange agent of such certificates representing such fractional
shares, will be entitled to receive cash in an amount equal to the product obtained by multiplying (a) the average of the closing
trading prices (as adjusted to reflect the Reverse Stock Split) of the Company’s common stock, as reported on the OTCQB,
during the 20 consecutive trading days ending on the trading day immediately prior to the date of the filing of the Certificate
of Amendment and (b) the fractional interest.
Accounting
Matters
The
par value per share of our common stock will remain unchanged at $0.001 per share after the Reverse Stock Split. As a result,
on the Effective Date, the stated capital on our consolidated balance sheet attributable to common stock will be reduced and the
additional paid-in-capital account will be increased by the amount by which the stated capital is reduced. Per share net income
or loss will be increased because there will be fewer shares of our common stock outstanding. We do not anticipate that any other
accounting consequences, including changes to the amount of stock-based compensation expense to be recognized in any period, will
arise as a result of the Reverse Stock Split.
Certain
Federal Income Tax Consequences
Each
shareholder is advised to consult their own tax advisor as the following discussion may be limited, modified or not apply based
on your own particular situation.
The
following is a summary of important tax considerations of the Reverse Stock Split. It addresses only shareholders who hold the
pre-Reverse Stock Split shares and post-Reverse Stock Split shares as capital assets. It does not purport to be complete and does
not address shareholders subject to special rules, such as financial institutions, tax-exempt organizations, insurance companies,
dealers in securities, mutual funds, foreign shareholders, shareholders who hold the pre-Reverse Stock Split shares as part of
a straddle, hedge, or conversion transaction, shareholders who hold the pre-Reverse Stock Split shares as qualified small business
stock within the meaning of Section 1202 of the Internal Revenue Code of 1986, as amended (the “Code”), shareholders
who are subject to the alternative minimum tax provisions of the Code, and shareholders who acquired their pre-Reverse Stock Split
shares pursuant to the exercise of employee stock options or otherwise as compensation. This summary is based upon current law,
which may change, possibly even retroactively. It does not address tax considerations under state, local, foreign, and other laws.
Furthermore, we have not obtained a ruling from the Internal Revenue Service or an opinion of legal or tax counsel with respect
to the consequences of the Reverse Stock Split.
The
Reverse Stock Split is intended to constitute a reorganization within the meaning of Section 368 of the Code. Assuming the Reverse
Stock Split qualifies as reorganization, a shareholder generally will not recognize gain or loss on the Reverse Stock Split, except
to the extent of cash, if any, received in lieu of a fractional share interest in the post-Reverse Stock Split shares. The aggregate
tax basis of the post-Reverse Stock Split shares received will be equal to the aggregate tax basis of the pre-Reverse Stock Split
shares exchanged (excluding any portion of the holder’s basis allocated to fractional shares), and the holding period of
the post-Reverse Stock Split shares received will include the holding period of the pre-Reverse Stock Split shares exchanged.
A
holder of the pre-Reverse Stock Split shares who receives cash will generally recognize gain or loss equal to the difference between
the portion of the tax basis of the pre-Reverse Stock Split shares allocated to the fractional share interest and the cash received.
Such gain or loss will be a capital gain or loss and will be short term if the pre-Reverse Stock Split shares were held for one
year or less and long term if held more than one year. No gain or loss will be recognized by us as a result of the Reverse Stock
Split.
PLEASE
CONSULT YOUR OWN TAX ADVISOR REGARDING THE U.S. FEDERAL, STATE, LOCAL, AND FOREIGN INCOME AND OTHER TAX CONSEQUENCES OF THE REVERSE
STOCK SPLIT IN YOUR PARTICULAR CIRCUMSTANCES UNDER THE INTERNAL REVENUE CODE AND THE LAWS OF ANY OTHER TAXING JURISDICTION.
No
Appraisal Rights
Shareholders
have no rights under DGCL or under our charter documents to exercise dissenters’ rights of appraisal with respect to the
Reverse Stock Split.
Anti-Takeover
Effects of the Reverse Stock Split
The
overall effect of the Reverse Stock Split may be to render more difficult the accomplishment of mergers or the assumption of control
by a principal shareholder and thus make the removal of management more difficult.
The
effective increase in our authorized and unissued shares as a result of the Reverse Stock Split could potentially be used by our
Board to thwart a takeover attempt. The over-all effects of this might be to discourage, or make it more difficult to engage in,
a merger, tender offer or proxy contest, or the acquisition or assumption of control by a holder of a large block of our securities
and the removal of incumbent management. The Reverse Stock Split could make the accomplishment of a merger or similar transaction
more difficult, even if it is beneficial to shareholders. Our Board might use the additional shares to resist or frustrate a third-party
transaction, favored by a majority of the independent shareholders that would provide an above-market premium, by issuing additional
shares to frustrate the takeover effort.
As
discussed above, the reasons for the Reverse Stock Split is to increase the ability of institutions to purchase our common stock
and the interest in our common stock by analysts and brokers as well as move us closer to meeting the Nasdaq initial listing standards.
This Reverse Stock Split is not the result of management’s knowledge of an effort to accumulate the Company’s securities
or to obtain control of the Company by means of a merger, tender offer, solicitation or otherwise.
Neither
our Certificate nor our Bylaws presently contain any provisions having anti-takeover effects and the Reverse Stock Split is not
a plan by our Board to adopt a series of amendments to our Certificate or Bylaws to institute an anti-takeover provision. We do
not have any plans or proposals to adopt other provisions or enter into other arrangements that may have material anti-takeover
consequences.
Additionally,
the Reverse Stock Split is not being conducted in an effort to take the Company private.
Voting
Securities and Principal Holders Thereof
The
following table sets forth the number of shares of our common stock beneficially owned as of the Record Date by (i) those persons
known by us to be owners of more than 5% of our common stock, (ii) each director, (iii) our Named Executive Officers and (iv)
all current executive officers and directors of the Company as a group. Unless otherwise specified in the notes to this table,
the address for each person is: c/o Cocrystal Pharma, Inc., 1860 Montreal Road. Tucker, GA 30084.
Title
of Class
|
|
Beneficial
Owner
|
|
Amount
and
Nature of Beneficial
Owner
(1)
|
|
|
Percent
of
Class
(1)
|
|
|
|
|
|
|
|
|
|
|
Directors and Executive Officers:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
Raymond Schinazi (2)
|
|
|
289,861,504
|
|
|
|
39.7
|
%
|
Common Stock
|
|
Phillip Frost (3)
|
|
|
106,875,148
|
|
|
|
14.7
|
%
|
Common Stock
|
|
Gary Wilcox (4)
|
|
|
16,948,606
|
|
|
|
2.3
|
%
|
Common Stock
|
|
Sam Lee (5)
|
|
|
13,087,847
|
|
|
|
1.8
|
%
|
Common Stock
|
|
Jane Hsiao (6)
|
|
|
9,106,948
|
|
|
|
1.3
|
%
|
Common Stock
|
|
Steven Rubin (7)
|
|
|
908,484
|
|
|
|
*
|
|
Common Stock
|
|
David Block (8)
|
|
|
343,696
|
|
|
|
*
|
|
Common Stock
|
|
James Martin (9)
|
|
|
-
|
|
|
|
0.0
|
%
|
Common Stock
|
|
All current directors and executive officers
as a group (8 persons)
|
|
|
437,132,233
|
|
|
|
60.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
5% Stockholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
Frost Gamma Investments Trust (10)
|
|
|
106,700,148
|
|
|
|
14.7
|
%
|
Common Stock
|
|
OPKO Health, Inc. (11)
|
|
|
63,634,259
|
|
|
|
8.8
|
%
|
*
Less than 1%
(1)
|
Applicable
percentages are based on 726,531,530 shares of common stock outstanding as of the record date. Beneficial ownership is determined
under the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of common
stock subject to options, warrants, and preferred stock currently exercisable or convertible within 60 days are deemed outstanding
for computing the percentage of the person holding such securities but are not deemed outstanding for computing the percentage
of any other person. The table includes shares of common stock, options, and warrants exercisable or convertible into common
stock and vested or vesting within 60 days. Unless otherwise indicated in the footnotes to this table, we believe that each
of the stockholders named in the table has sole voting and investment power with respect to the shares of common stock indicated
as beneficially owned by them.
|
(2)
|
Dr. Schinazi is a director.
Includes (i) 277,227,831 shares of common stock directly owned, (ii) 9,044,717
shares of common stock held by RFS Partners, LP., and (iii) 3,588,956 vested
options.
|
|
|
(3)
|
Dr.
Frost is a director. Includes (i) 106,500,148 shares of common stock held by Frost Gamma Investments Trust and (ii) 200,000
warrants held by Frost Gamma Investments Trust and 175,000 vested options. Dr. Frost is the trustee of Frost Gamma Investments
Trust. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited
partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost
Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is the sole shareholder of Frost-Nevada Corporation. Does not include securities
held by OPKO, a corporation of which Dr. Frost is the Chief Executive Officer and Chairman, concerning the securities of which
Dr. Frost does not hold voting and investment control. Dr. Frost disclaims beneficial ownership of the securities held by
Frost Gamma Investments Trust and OPKO except to the extent of any pecuniary interest therein. Address is 4400 Biscayne Boulevard,
Miami, FL 33137.
|
(4)
|
Dr. Wilcox is an executive officer and is a director.
Represents shares of common stock held by a trust for which Dr. Wilcox is a trustee.
|
|
|
(5)
|
Dr.
Lee is an executive officer.
|
|
|
(6)
|
Dr. Hsiao
is a director. Includes 3,435,294 shares of common stock held directly by Dr. Hsiao
and 5,496,654 shares of common stock held by Hsu Gamma Investment, L.P, for which
Dr. Hsiao serves as General Partner, and 175,000 vested options.
|
|
|
(7)
|
Mr.
Rubin is a director. Includes 733,484 shares of common stock and 175,000 vested options.
|
|
|
(8)
|
Dr.
Block is a director. Includes 168,696 shares of common stock and 175,000 vested options.
|
|
|
(9)
|
Mr.
Martin is an executive officer.
|
|
|
(10)
|
Dr.
Frost has voting and investment control over the securities held by Frost Gamma Investments Trust. See Footnote 3 above. Includes
(i) 106,500,148 shares of common stock and (ii) 200,000 warrants. Address is 4400 Biscayne Boulevard, Miami, FL 33137.
|
|
|
(11)
|
Includes
(i) 62,634,259 shares of common stock and (ii) 1,000,000 warrants. Dr. Frost is the Chief Executive Officer and Chairman
of OPKO. However, he does not hold voting and investment control over, and disclaims beneficial ownership of, the securities
held by OPKO. Address is 4400 Biscayne Boulevard, Miami, FL 33137.
|
Where
You Can Find More Information
You
can read and copy any materials that the Company files with the SEC at the SEC’s Public Reference Room at 100 F Street,
N.E., Washington, D.C. 20549. You can obtain information about the operation of the SEC’s Public Reference Room by calling
the SEC at 1-800-SEC-0330. The SEC also maintains a website that contains information we file electronically with the SEC, which
you can access over the Internet at
www.sec.gov
. Copies of these materials may also be obtained by mail from the Public
Reference Section of the SEC at 100 F Street, N.E., Washington, D.C. 20549 at prescribed rates.
Delivery
of Documents to Security Holders Sharing an Address
If
you and one or more shareholders share the same address, it is possible that only one Information Statement was delivered to your
address. Any registered shareholder who wishes to receive a separate copy of the Information Statement at the same address now
or in the future may call the Company at (404) 601-1430 or mail a request to receive separate copies to Cocrystal Pharma, Inc.,
1860 Montreal Road. Tucker, GA 30084 Attention: Corporate Secretary, and we will promptly deliver the Information Statement to
you upon your request. Shareholders who received multiple copies of this Information Statement at a shared address and who wish
to receive a single copy may direct their request to the same address.
By
Order of the Board of Directors
/s/
Raymond
Schinazi
|
|
Raymond
Schinazi
|
|
Chairman
of the Board of Directors
|
|
Appendix
A
CERTIFICATE
OF AMENDMENT
TO
CERTIFICATE
OF INCORPORATION
Cocrystal
Pharma, Inc. (the ‘‘Company’’), a corporation organized and existing under the General Corporation Law
of the State of Delaware (the ‘‘Delaware General Corporation Law’’), hereby certifies as follows:
1.
The Company was incorporated by the filing of a Certificate of Incorporation with the Secretary of State of Delaware on November
21, 2014.
2.
Pursuant to Sections 242 and 228 of the Delaware General Corporation Law, the amendment herein set forth has been duly approved
by the Board of Directors and holders of a majority of the outstanding capital stock of the Company.
3.
Article FOURTH of the Certificate of Incorporation is amended by adding the following at the end thereof:
As
of the close of business on October ___, 20__ (4:01 p.m. Eastern Daylight Time) (the ‘‘Reverse Split Date’’),
each ___ shares of common stock issued and outstanding immediately prior to the Reverse Split Date (referred to in this paragraph
as the ‘‘Old Common Stock’’) automatically and without any action on the part of the holder thereof will
be reclassified and changed into ___ share of new common stock, par value $.001 per share (referred to in this paragraph as the
‘‘New Common Stock’’), subject to the treatment of fractional share interests as described below. Each
holder of a certificate or certificates that immediately prior to the Reverse Split Date represented outstanding shares of Old
Common Stock (the ‘‘Old Certificates’’) will be entitled to receive, upon surrender of such Old Certificates
to the Company for cancellation, a certificate or certificates (the ‘‘New Certificate’’, whether one or
more) representing the number of whole shares of the New Common Stock into which and for which the shares of the Old Common Stock
formerly represented by such Old Certificates so surrendered are reclassified under the terms hereof. From and after the Reverse
Split Date, Old Certificates shall represent only the right to receive New Certificates pursuant to the provisions hereof. No
certificates or scrip representing fractional share interests in New Common Stock will be issued. In lieu of any such fractional
shares of New Common Stock, each shareholder with a fractional share will be entitled to receive, upon surrender of Old Certificates
to the Company for cancellation, an amount in cash equal to the product of (i) the average of the closing trading prices (as adjusted
to reflect the reverse stock split) of the Company’s common stock, as reported on the OTCQB, during the 20 consecutive trading
days ending on the trading day immediately prior to the Reverse Split Date and (ii) such fractional interest. If more than one
Old Certificate shall be surrendered at one time for the account of the same shareholder, the number of full shares of New Common
Stock for which New Certificates shall be issued shall be computed on the basis of the aggregate number of shares represented
by the Old Certificates so surrendered. In the event that the Company determines that a holder of Old Certificates has not tendered
all his, her or its certificates for exchange, the Company shall carry forward any fractional share until all certificates of
that holder have been presented for exchange. The Old Certificates surrendered for exchange shall be properly endorsed and otherwise
in proper form for transfer. From and after the Reverse Split Date, the amount of capital represented by the shares of the New
Common Stock into which and for which the shares of the Old Common Stock are reclassified under the terms hereof shall be an amount
equal to the product of the number of issued and outstanding shares of New Common Stock and the $0.001 par value of each such
share.
4.
This Certificate of Amendment to Certificate of Incorporation was duly adopted and approved by the shareholders of the Company
on the __________ day of _________, 201_ in accordance with Section 242 of the Delaware General Corporation Law.
IN
WITNESS WHEREOF, the undersigned has executed this Certificate of Amendment to Certificate of Incorporation as of ______, 201__.
|
COCRYSTAL
PHARMA, INC.
|
|
|
|
By
|
|
|
|
Gary
Wilcox, Interim Chief Executive Officer
|